Literature DB >> 16095491

Induction of obliterative airway disease by anti-HLA class I antibodies.

Takahiro Maruyama1, Andrés Jaramillo, Kishore Narayanan, Toru Higuchi, T Mohanakumar.   

Abstract

Anti-HLA class I Abs are associated with the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation. BOS is characterized histologically by fibrosis and airway epithelial cell apoptosis. We have previously shown that anti-HLA class I Abs induce proliferation, growth factor production and apoptosis in airway epithelial cells in vitro. Thus, this study was designed to determine whether anti-HLA class I Abs alone could induce obliterative airway disease (OAD) in heterotopic murine tracheal allografts. Toward this, HLA-A*0201-transgenic tracheal allografts were transplanted into Rag1-deficient mice treated with the W6/32 anti-HLA class I mAb. Allografts were harvested at days +30, +45, +60 and +90. Allografts displayed epithelial metaplasia by day +45, epithelial destruction and mild cellular infiltration by day +60 and complete lumen obliteration and moderate cellular infiltration by day +90. Anti-HLA class I Abs induced the production of several growth factors and growth factor receptors and apoptosis of parenchymal cells in the allograft. In addition, anti-HLA class I Abs induced macrophages and granulocytes infiltration. The results from this study demonstrate that anti-HLA class I Abs play an important role in the pathogenesis of OAD by inducing growth factor production, apoptosis and chemotaxis of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095491     DOI: 10.1111/j.1600-6143.2005.00999.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

Review 1.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

2.  Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies.

Authors:  Peter H Hagedorn; Christopher M Burton; Jørn Carlsen; Daniel Steinbrüchel; Claus B Andersen; Eli Sahar; Eytan Domany; Irun R Cohen; Henrik Flyvbjerg; Martin Iversen
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

Review 3.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

4.  Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation.

Authors:  Ramsey R Hachem; Roger D Yusen; Bryan F Meyers; Aviva A Aloush; Thalachallour Mohanakumar; G Alexander Patterson; Elbert P Trulock
Journal:  J Heart Lung Transplant       Date:  2010-06-16       Impact factor: 10.247

Review 5.  Effect of antibodies on endothelium.

Authors:  X Zhang; E F Reed
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

Review 6.  Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.

Authors:  Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

7.  C4d deposition and cellular infiltrates as markers of acute rejection in rat models of orthotopic lung transplantation.

Authors:  Kazunori Murata; Takekazu Iwata; Shinji Nakashima; Karen Fox-Talbot; Zhiping Qian; David S Wilkes; William M Baldwin
Journal:  Transplantation       Date:  2008-07-15       Impact factor: 4.939

8.  Antibody-Mediated Lung Transplant Rejection.

Authors:  Ramsey Hachem
Journal:  Curr Respir Care Rep       Date:  2012-09

Review 9.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

Review 10.  MHC class I signaling: new functional perspectives for an old molecule.

Authors:  E W Tsai; E F Reed
Journal:  Tissue Antigens       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.